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Introduction
Lung development is a long lasting process,
starting during fetal life, and continuing in the early
postnatal years. A wide range of pathologies may
interfere with normal lung development, some of
them leading to permanent sequelae. In this article
the long-term pulmonary consequences of two
intra-thoracic malformations are discussed, all of
them potentially being diagnosed in the early prena-
tal period(2).
Esophageal Atresia (EA) and Congenital
Diaphragmatic Hernia (CDH) are both severe con-
genital anatomical anomalies requiring neonatal
surgery and intensive care treatment. Many impor-
tant molecules, such as heat shock proteins, are
likely involved in early neonatal lung inflammation
in case of major congenital malformations requiring
surgical repair and prolonged respiratory assistance
and their role in these complex metabolic pathways
is currently investigated(3,4).
Newborns with major congenital malforma-
tions show high incidence of mortality and long
term sequelae(5), especially if other risk factors are
present such us prematurity, twinning and nosoco-
mial infections(6-13). Array-CGH (comparative
genomic hybridization) analysis has led to the dis-
covery of several submicroscopic genomic variants
(duplications and deletions)(14,15), which are respon-
sible for many syndromic conditions with congeni-
tal malformations, but none has been clearly associ-
ated with EA and CDH till now(18,21).
Continuous progress in medical and surgical
neonatal care in recent years had led to improved
survival of critical neonates with the consequence
of an increase of patients with respiratory and gas-
trointestinal associated pathologies.  
Esophageal atresia
Esophageal atresia is a congenital anomaly of
the esophagus which in most cases involves the tra-
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Thoracic congenital malformations may be associated with long-term pulmonary morbidity. Certainly, this is the case for
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chea (78-95%). It is due to an abnormal develop-
ment of the esophagus from the anterior intestine,
occurring between week 4 and 10 of intrauterine
life. The overall European prevalence is 2,43 per
10.000 births(22). Survival of newborns with EA is
only possible with surgical correction. Survival
rates after surgery in dedicated centres are reported
to be around 90% including patients with severe
associated anomalies and up to almost 100% in
term infants without associated anomalies(23-25). To
achieve these outcomes, as well as a surgical tech-
nique, careful preoperative management (early
diagnosis, investigation of associated anomalies,
suction of the upper pouch, prevention and treat-
ment of gastric and bowel distension) and accurate
postoperative care (post-operative analgesia and
ventilation, management of trans-anastomotic and
chest tube, prevention, early recognition and treat-
ment of complications) are mandatory.
After EA repair in infancy, gastroesophageal
reflux (GER), esophageal dismotility and respirato-
ry problems are common. Significant esophageal
morbidity associated with EA extends into adult-
hood. Follow-up for children with EA tends to
focus on gastrointestinal pathologic condition(26,28).
Respiratory pathologic conditions, however, are
also common and seem equally important.
Approximately 10-20% have severe tracheobron-
chomalacia with airway instability and collapse(29).
In the few adult studies on EA patients, occurrence
of respiratory symptoms ranges from 33 to 41%(30).
Recurrent respiratory infections, persistent cough,
and wheeze are typical symptoms in childhood(31)
and in adolescence(31), with a tendency to improve
with age. However, repeated infections, aspiration,
and persistent tracheoesophageal fistula may result
in irreversible lung damage with bronchiectasis and
chronic pulmonary disease(32). Adults with repaired
EA have significantly more respiratory symptoms
and infections, as well as more asthma and aller-
gies, than the general populations. Thoracotomy-
induced rib fusion and gastroesophageal reflux are
the most significant risk factors for the restrictive
ventilation defect that occurs in almost half the
patients.
Moreover, congenital vertebral defects can
lead to restrictive pulmonary function tests (PFTs).
In a series of 101 EA adult patients, pulmonary
function tests showed obstruction in 21%, restric-
tion in 21% and both in 36% of the patients. Only
20% had normal pulmonary function. Nearly half
the patients had bronchial hyperresponsiveness in
histamine challenge test, and in 15% it was compat-
ible with asthma. A total of 11% had elevated
exhaled nitric oxide levels indicating airway
inflammation. Over half the patients with repaired
EA are likely to develop scoliosis. Risk for scoliosis
is increased 13-folds after repair of EA in relation
to that of the general population(32). 
Beucher et al. showed that respiratory symp-
toms are under-detected by physicians and patients,
and indicates that PFTs should be systematically
performed, early and regularly, even in the absence
of clear clinical symptoms. In fact they showed that
PFTs and cardiopulmonary stress test were abnor-
mal in many children not complaining of breathing
difficulties(33). Montgomery et al., in an older study,
indicated that the functional abnormalities found by
PTFs had no impact on exercise tolerance(34). On the
other hand, Gischler et al. suggested a decrease in
maximal exercise tolerance(35). However the clinical
symptoms are often minimized, depriving patients
of appropriate treatment. Early and prolonged mon-
itoring by multidisciplinary specialists is critical to
improve long-term respiratory prognosis(33).
Congenital diaphragmatic hernia 
CDH consist of a posterolateral defect of the
diaphragm, generally located on the left side, that
allows passage of the abdominal viscera into the
thorax. The mediastinum is displaced to contralater-
al side, the lungs are hypoplastic and their arterioles
are abnormal causing pulmonary hypertension. The
incidence is < 5 in 10.000 live-births(36). Prenatal
diagnosis of CDH now occurs routinely and allows
to plan the delivery of high-risk infants in adequate
structures or to perform prenatal treatment
(reversible fetoscopic tracheal obstruction) in cases
with severe lung hypoplasia and grim prognosis.
New treatment modalities such as gentle ventilation
with permissive hypercapnia, high frequency oscil-
latory ventilation (HFOV), inhaled nitric oxide
(iNO), and extracorporeal membrane oxygenation
(ECMO) have improved survival rates in CDH
patients(37). The best hospital series report 80% sur-
vival rate but it remains around 50% in population-
based series in which abortion, stillbirths and pre-
hospital deaths were considered(38). As a conse-
quence of the increased survival of more severely
affected infants, the long-term outcome of survivors
with CDH became an important issue in the man-
agement of such patients, because CDH survivors
can suffer long-term sequelae, including pulmonary
and gastrointestinal problems, neurodevelopmental
morbidity, and orthopaedic disorders(39). Despite
most adolescent CDH survivors are healthy and
enjoy normal lifestyles, in a significant portion of
patients long-term pulmonary sequelae are
detectable and seem to result not only from residual
lung hypoplasia with persistent pulmonary hyper-
tension but also from lung injury induced by venti-
lator support(40). During gestation, the normal air-
way develops from the 4th to the 16th week. There
is successive branching of bronchi and pulmonary
arteries in canalicular (17-27 w.g.) and saccular
(27-35 w.g.) stages. Alveolar development, which
begins at around 20 weeks of gestational age, is
largely completed in childhood by the age of 2-3
years. After this, lung growth mainly occurs by the
enlargement of existing alveoli. Thus, any stimulus
or insult imposed during fetal or early postnatal life
could permanently alter the structure and physiolo-
gy of the respiratory system with possible long term
consequences.
In CDH patients, most have pulmonary
hypoplasia which affects both lungs, with a reduced
number of airway generations and pulmonary arter-
ies. In CDH survivors, lung hypoplasia persists as
demonstrated by ventilation/perfusion radionuclide
tests, but the value of V/Q scans in future pul-
monary outcome is still a matter of debate.
However, more recent unpublished data suggest
that children with the most severe V/Q mismatches
develop significant limitations in exercise tolerance
in middle school(41). 
Obstructive symptoms such as bronchospasm
or wheezing are frequently reported in CDH sur-
vivors, and a high proportion had been diagnosed
with asthma. These symptoms are perceived to
decline with aging, although abnormalities in pul-
monary function tests persist(42). Actually, CDH sur-
vivors may have obstructive, restrictive, and com-
bined pulmonary function anomalies(43). A decreased
compliance of the chest wall may contribute to PFT
abnormalities.
Recurrent pneumonia or a past history of
pneumonia has been found in 26 to 39% of CDH
survivors(44). Muratore et al. found a high prevalence
of viral bronchiolitis in CDH survivors less than 3
years old, despite aggressive antiviral therapy.
Since Respiratory Syncitial Virus (RSV) is the most
frequent pathogen in these patients, they suggest
active RSV prophylaxis in CDH survivors during
the period of maximal exposure to the virus(45), even
if large multicentre studies are needed to clarify this
proposal. Chronic lung disease (CLD) has been
reported in CDH survivors, but its incidence is
unclear. Van den Hout et al found that 41% had
CLD.  The higher prevalence of CLD has been
reported in patients requiring ECMO or patch repair
of the diaphragmatic defect(46). 
In conclusion, CDH survivors present ongoing
morbidities during infancy and childhood. This
morbidity is more prevalent in the first years of life
and there is some improvement with growth.
Although most CDH survivors are clinically nor-
mal, many of them present subclinical abnormali-
ties in their chest radiographs, lung scintigraphy
and/or pulmonary function tests. Whether these
abnormalities will remain silent for all their lives or
will manifest in the event of declining compliance
(eg. scoliosis, surgery, or pneumonia), or at a longer
follow-up is still unknown(39). Therefore, CDH sur-
vivors are a group of patients that requires long-
term periodic follow-up in a multidisciplinary set-
ting to provide adequate support and improve their
quality of life(47).
Conclusions
Prenatal prediction of postnatal morbidity is a
frequently asked question by parents. The potential
of successful prediction is limited as many postna-
tal factors interfering with morbidity cannot be pre-
dicted (Fig. 1)(1). 
Measurement of lung function and exercise
capacity are helpful for evaluating postnatal lung
development(1). 
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Fig. 1: Flow chart of factors determining long-term
outcome of esophageal atresia (Modified from
Sistonen SJ et al., 2011).
Respiratory symptoms are under-detected by
physicians and patients, therefore PFTs should be
systematically performed, early and regularly, even
in the absence of clear clinical symptoms. Early and
prolonged monitoring by multidisciplinary specialist
is critical to improve long-term respiratory prognosis. 
Multidisciplinary long term follow-up is essen-
tial for surgical newborns because of the multi-organ
array of morbidities and it has recently been advocat-
ed by the American Academy of Pediatrics for
CDH(47). The suggestions provided, however, should
be individualized depending on the specific needs of
each infant; and the effect of multidisciplinary fol-
low-up clinics needs to be objectivized by appropriate
prospective cohort studies.
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